Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCSK9 Inhibitor for AVF Patency After Angioplasty
NCT06034691Unknown
- Sponsor
- Renji Hospital
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in hemodialysis vascular access failure (2 arms), sponsored by Renji Hospital. Primary endpoints: Value of vessel diameter at 48 weeks, Value of volume of blood flow at 48 weeks and 2 more. Status: unknown.
02
Conditions
hemodialysis vascular access failure
Beyond the preview
Go deeper on NCT06034691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06034691.